Geron reported $-25674000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acceleron Pharma XLRN:US $ -70.63M 6.97M
Amgen AMGN:US $ 2378M 1550M
Aurinia Pharmaceuticals Inc AUP:CN -47134000 3.41M
Bio Techne TECH:US $ 63.22M 5.36M
Cti Biopharma CTIC:US $ -23.38M 3.88M
Cytokinetics CYTK:US $ -69.2M 14.4M
Esperion Therapeutics ESPR:US $ -55745000 23.21M
Exelixis EXEL:US $ 51.62M 71.39M
Genmab GEN:DC 890M 103M
Geron GERN:US $ -25.67M 3.22M
Gilead Sciences GILD:US $ 3842M 1596M
Macrogenics MGNX:US $ -52987000 12.71M
Novartis NOVN:VX 3.23B 246M
Novavax NVAX:US $ -307.14M 38.68M
Pain Therapeutics PTIE:US $ -9753000 4.62M
Seattle Genetics SGEN:US $ -297.96M 208.36M
YTE INCY:US $ 235.41M 94.57M